The Manufacturers Life Insurance Company Reduces Stock Position in Houlihan Lokey, Inc. (NYSE:HLI)

The Manufacturers Life Insurance Company trimmed its holdings in Houlihan Lokey, Inc. (NYSE:HLI) by 1.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,530 shares of the financial services provider’s stock after selling 486 shares during the period. The Manufacturers Life Insurance Company’s holdings in Houlihan Lokey were worth $7,559,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of HLI. Barclays PLC lifted its holdings in shares of Houlihan Lokey by 21.4% in the third quarter. Barclays PLC now owns 36,821 shares of the financial services provider’s stock worth $5,818,000 after buying an additional 6,483 shares in the last quarter. GAMMA Investing LLC lifted its stake in Houlihan Lokey by 21.6% in the 4th quarter. GAMMA Investing LLC now owns 1,730 shares of the financial services provider’s stock worth $300,000 after purchasing an additional 307 shares in the last quarter. Fulton Bank N.A. boosted its holdings in Houlihan Lokey by 5.8% in the 4th quarter. Fulton Bank N.A. now owns 7,621 shares of the financial services provider’s stock valued at $1,323,000 after purchasing an additional 418 shares during the period. Wealth Enhancement Advisory Services LLC grew its position in shares of Houlihan Lokey by 1.8% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 26,706 shares of the financial services provider’s stock valued at $4,220,000 after purchasing an additional 482 shares in the last quarter. Finally, PFW Advisors LLC bought a new position in shares of Houlihan Lokey in the fourth quarter worth $243,000. Institutional investors own 78.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on HLI. JPMorgan Chase & Co. reduced their target price on Houlihan Lokey from $172.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, January 29th. Wells Fargo & Company decreased their price objective on shares of Houlihan Lokey from $179.00 to $170.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 8th. UBS Group lifted their target price on shares of Houlihan Lokey from $229.00 to $230.00 and gave the company a “buy” rating in a research report on Wednesday, January 29th. JMP Securities reissued a “market perform” rating on shares of Houlihan Lokey in a report on Wednesday, January 29th. Finally, Morgan Stanley dropped their price objective on shares of Houlihan Lokey from $190.00 to $156.00 and set an “overweight” rating for the company in a report on Monday, April 7th. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $183.40.

Houlihan Lokey Price Performance

NYSE:HLI opened at $163.08 on Wednesday. Houlihan Lokey, Inc. has a 1-year low of $127.14 and a 1-year high of $192.10. The business has a 50 day moving average of $158.35 and a 200 day moving average of $171.43. The company has a market capitalization of $11.44 billion, a price-to-earnings ratio of 31.12 and a beta of 0.82.

About Houlihan Lokey

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.